On May 28, 2021, the Chairwoman of the World Health Organization (WHO) in Kazakhstan, Caroline Clarinval, met with the Director General of the Research Institute for Biological Safety Problems.
During the meeting, which was also attended by employees of the Ministry of Foreign Affairs of the Republic of Kazakhstan, the possibility of registering the Kazakh QazVac vaccine with the WHO was considered.
WHO is the most important partner of the authorities, as the organization develops technical recommendations as part of the response to COVID-19, as well as provides other technically qualified resources in such areas of health care as epidemiology, risk communication, logistics, and others, which is an important factor today.
At the end of the meeting, the parties decided to cooperate on the registration of Kazakhstan’s QazVac vaccine.
Illustrative photo: from open sources